These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19396704)

  • 21. Quantitative neural indicators of liability to schizophrenia: implications for molecular genetic studies.
    Cannon TD; Gasperoni TL; van Erp TG; Rosso IM
    Am J Med Genet; 2001 Jan; 105(1):16-9. PubMed ID: 11424984
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibility locus on chromosome 1q23-25 for a schizophrenia subtype resembling deficit schizophrenia identified by latent class analysis.
    Holliday EG; McLean DE; Nyholt DR; Mowry BJ
    Arch Gen Psychiatry; 2009 Oct; 66(10):1058-67. PubMed ID: 19805696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neurobiological determinants of schizophrenic diseases. Concept, strategy and methods of a research program].
    Gaebel W; Maier W
    Nervenarzt; 1993 Jul; 64(7):415-26. PubMed ID: 8396208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early visual sensory deficits as endophenotypes for schizophrenia: high-density electrical mapping in clinically unaffected first-degree relatives.
    Yeap S; Kelly SP; Sehatpour P; Magno E; Javitt DC; Garavan H; Thakore JH; Foxe JJ
    Arch Gen Psychiatry; 2006 Nov; 63(11):1180-8. PubMed ID: 17088498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Finding suitable phenotypes for genetic studies of schizophrenia: heritability and segregation analysis.
    Aukes MF; Alizadeh BZ; Sitskoorn MM; Selten JP; Sinke RJ; Kemner C; Ophoff RA; Kahn RS
    Biol Psychiatry; 2008 Jul; 64(2):128-36. PubMed ID: 18295748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [P50 sensory gating disorders of auditory evoked potentials (AEP) in persons with schizophrenia].
    Wegrzyn J
    Psychiatr Pol; 2004; 38(5):833-45. PubMed ID: 15523930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid: identification of diagnostic markers for schizophrenia.
    Schwarz E; Bahn S
    Expert Rev Mol Diagn; 2008 Mar; 8(2):209-16. PubMed ID: 18366307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current status of biochemical hypotheses in the pathogenesis of schizophrenia].
    Kornhuber J; Weller M
    Nervenarzt; 1994 Nov; 65(11):741-54. PubMed ID: 7816150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Psychopathology of schizophrenia and brain imaging].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why schizophrenia genetics needs epigenetics: a review.
    Thibaut F
    Psychiatr Danub; 2012 Mar; 24(1):25-7. PubMed ID: 22447081
    [No Abstract]   [Full Text] [Related]  

  • 31. Animal models for schizophrenia via in utero gene transfer: understanding roles for genetic susceptibility factors in brain development.
    Kamiya A
    Prog Brain Res; 2009; 179():9-15. PubMed ID: 20302813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The utility of biomarker discovery approaches for the detection of disease mechanisms in psychiatric disorders.
    Schwarz E; Bahn S
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S133-6. PubMed ID: 18193070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress in defining the biological causes of schizophrenia.
    Pickard B
    Expert Rev Mol Med; 2011 Jul; 13():e25. PubMed ID: 21794196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translating potential biomarker candidates for schizophrenia and depression to animal models of psychiatric disorders.
    Kluge W; Alsaif M; Guest PC; Schwarz E; Bahn S
    Expert Rev Mol Diagn; 2011 Sep; 11(7):721-33. PubMed ID: 21902534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Endophenotype--a new concept for biological characterization of psychiatric disorders].
    Zobel A; Maier W
    Nervenarzt; 2004 Mar; 75(3):205-14. PubMed ID: 15021921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intermediate phenotypes in schizophrenia: a selective review.
    Preston GA; Weinberger DR
    Dialogues Clin Neurosci; 2005; 7(2):165-79. PubMed ID: 16262211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Schizophrenia in the Era of Brain Complexity.
    Collin G; Kahn RS
    J Nerv Ment Dis; 2016 Aug; 204(8):561-3. PubMed ID: 27479610
    [No Abstract]   [Full Text] [Related]  

  • 38. [The genetics of schizophrenia: back to the clinic?].
    Krebs MO; Joober R
    Encephale; 2010 Apr; 36(2):91-3. PubMed ID: 20434624
    [No Abstract]   [Full Text] [Related]  

  • 39. Schizophrenia, "just the facts": what we know in 2008 Part 3: neurobiology.
    Keshavan MS; Tandon R; Boutros NN; Nasrallah HA
    Schizophr Res; 2008 Dec; 106(2-3):89-107. PubMed ID: 18799287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia?
    Bender S; Weisbrod M; Resch F
    J Neural Transm (Vienna); 2007 Sep; 114(9):1199-215. PubMed ID: 17514428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.